These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 14700005

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
    Park SH, Park HY, Kang JW, Park JS, Shin KJ, Kim CH, Suk KT, Baik GH, Kim JB, Kim DJ, Lee HY.
    Hepatogastroenterology; 2012; 59(120):2548-51. PubMed ID: 23178621
    [Abstract] [Full Text] [Related]

  • 44. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V, Pranculis A, Mitraite D, Jonaitis L, Petrenkiene V, Kupcinskas L.
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Portal pressure should be measured on suspicion of portal hypertension].
    Møller S, Bendtsen F.
    Ugeskr Laeger; 2010 Dec 06; 172(49):3411-3. PubMed ID: 21129318
    [Abstract] [Full Text] [Related]

  • 48. Evaluation and treatment of esophageal varices in the cirrhotic patient.
    Ashkenazi E, Kovalev Y, Zuckerman E.
    Isr Med Assoc J; 2013 Feb 06; 15(2):109-15. PubMed ID: 23516775
    [Abstract] [Full Text] [Related]

  • 49. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis.
    Avgerinos A, Armonis A, Stefanidis G, Mathou N, Vlachogiannakos J, Kougioumtzian A, Triantos C, Papaxoinis C, Manolakopoulos S, Panani A, Raptis SA.
    Hepatology; 2004 Jun 06; 39(6):1623-30. PubMed ID: 15185303
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Risk factors influencing the outcome of portal and mesenteric vein thrombosis.
    Berney T, Morales M, Broquet PE, Mentha G, Morel P.
    Hepatogastroenterology; 1998 Jun 06; 45(24):2275-81. PubMed ID: 9951910
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
    Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V, Peck-Radosavljevic M.
    Dig Liver Dis; 2009 Dec 06; 41(12):902-6. PubMed ID: 19501032
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.